کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2137568 1087851 2010 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Practical use of azacitidine in higher-risk myelodysplastic syndromes: An expert panel opinion
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی تحقیقات سرطان
پیش نمایش صفحه اول مقاله
Practical use of azacitidine in higher-risk myelodysplastic syndromes: An expert panel opinion
چکیده انگلیسی

Azacitidine is currently the only drug to have shown a significant survival benefit over conventional care regimens in patients with International Prognostic Scoring System (IPSS) intermediate-2 (Int-2) and high-risk myelodysplastic syndromes (MDS), establishing it as an important new treatment for these individuals. However, several aspects of the practical use of azacitidine remain uncertain. This manuscript outlines recommendations discussed by a panel of experts, providing a practical guide for physicians to ensure optimal management of Int-2 and high-risk patients receiving azacitidine.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Leukemia Research - Volume 34, Issue 11, November 2010, Pages 1410–1416
نویسندگان
, , , , , , , ,